Gisela Schwab, President, Prod Development & Med Aff & CMO at EXELIXIS, INC. (EXEL), sold 123,000 shares at $21.66 ($2.7M) on 2019-02-14, disclosed to the SEC on 2019-02-15.
Seasonal sale ($2.7M) by President, Prod Development & Med Aff & CMO — this insider has traded EXEL in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.66 | 100,000 | $2.2M | 80.9% |
| 2 | $22.20 | 23,000 | $511K | 19.1% |
| Total | $21.76 avg | 123,000 | $2.7M | 100% |
| Filing → |
| EXEL | SELL | 2021-04-02 | $1.1M | — | Filing → |
| EXEL | SELL | 2021-02-19 | $2.2M | — | Filing → |
| EXEL | SELL | 2020-06-05 | $2.3M | — | Filing → |